Session

IBD (Posters)

HUMAN NEUTROPHIL ELASTASE DERIVED FRAGMENT OF CALPROTECTIN (S100A9) IS A SERUM BIOMARKER (CPA9-HNE) FOR MONITORING OF ANTI-TNFA TREATMENT RESPONSE IN CROHN'S DISEASE
HUMAN NEUTROPHIL ELASTASE DERIVED FRAGMENT OF CALPROTECTIN (S100A9) IS A SERUM BIOMARKER (CPA9-HNE) FOR MONITORING OF ANTI-TNFA TREATMENT RESPONSE IN CROHN'S DISEASE

DIGESTIVE FISTULAS IN CROHN'S DISEASE (CD) OTHER THAN ANO-PERINEAL MANIFESTATIONS (APM): WHAT PROGNOSIS?
DIGESTIVE FISTULAS IN CROHN'S DISEASE (CD) OTHER THAN ANO-PERINEAL MANIFESTATIONS (APM): WHAT PROGNOSIS?

COLORECTAL CANCER SURVEILLANCE IN COMPLEX IBD PATIENTS WITH STRICTURES
COLORECTAL CANCER SURVEILLANCE IN COMPLEX IBD PATIENTS WITH STRICTURES

SINGLE CELL RNA SEQUENCING IDENTIFIES DISTINCT INTESTINAL INFLAMMATION PATTERNS BETWEEN PRIMARY SCLEROSING CHOLANGITIS-ASSOCIATED COLITIS AND ULCERATIVE COLITIS
SINGLE CELL RNA SEQUENCING IDENTIFIES DISTINCT INTESTINAL INFLAMMATION PATTERNS BETWEEN PRIMARY SCLEROSING CHOLANGITIS-ASSOCIATED COLITIS AND ULCERATIVE COLITIS

PSYCHOLOGICAL MORBIDITY PREDICTS MALADAPTIVE DECISION-MAKING IN PEOPLE WITH INFLAMMATORY BOWEL DISEASE
PSYCHOLOGICAL MORBIDITY PREDICTS MALADAPTIVE DECISION-MAKING IN PEOPLE WITH INFLAMMATORY BOWEL DISEASE

SAFETY, TOLERABILITY AND PHARMACOKINETICS OF NX-13 IN A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1 STUDY IN NORMAL HEALTHY VOLUNTEERS
SAFETY, TOLERABILITY AND PHARMACOKINETICS OF NX-13 IN A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1 STUDY IN NORMAL HEALTHY VOLUNTEERS

PATIENTS WITH NEWLY DIAGNOSED FISTULIZING PERIANAL CROHN'S DISEASE HAVE DISTINCT MICROBIAL SIGNATURE
PATIENTS WITH NEWLY DIAGNOSED FISTULIZING PERIANAL CROHN'S DISEASE HAVE DISTINCT MICROBIAL SIGNATURE

INFLUENCE OF COVID-19 ON INFLAMMATORY BOWEL DISEASE PATIENTS AND BIOLOGICAL TREATMENT
INFLUENCE OF COVID-19 ON INFLAMMATORY BOWEL DISEASE PATIENTS AND BIOLOGICAL TREATMENT

PROACTIVE THERAPEUTIC DRUG MONITORING OF ANTI-TNF AGENTS IS ASSOCIATED WITH HIGHER MUCOSAL HEALING RATES IN CROHN'S DISEASE
PROACTIVE THERAPEUTIC DRUG MONITORING OF ANTI-TNF AGENTS IS ASSOCIATED WITH HIGHER MUCOSAL HEALING RATES IN CROHN'S DISEASE

FECAL CALPROTECTIN: ROLE IN MONITORING ILEAL CROHN'S DISEASE ACTIVITY DETECTED BY INTESTINAL ULTRASONOGRAPHY
FECAL CALPROTECTIN: ROLE IN MONITORING ILEAL CROHN'S DISEASE ACTIVITY DETECTED BY INTESTINAL ULTRASONOGRAPHY

CLINICAL CHARACTERISTICS ASSOCIATED WITH BIOCHEMICAL REMISSION THREE MONTHS AFTER DIAGNOSIS OF ULCERATIVE COLITIS
CLINICAL CHARACTERISTICS ASSOCIATED WITH BIOCHEMICAL REMISSION THREE MONTHS AFTER DIAGNOSIS OF ULCERATIVE COLITIS

ASSESSEMENT OF CUMULATIVE BOWEL DAMAGE USING LEMANN INDEX AND MARIA SCORE IN SURGICALLY NAIVE PATIENTS WITH CROHN'S DISEASE
ASSESSEMENT OF CUMULATIVE BOWEL DAMAGE USING LEMANN INDEX AND MARIA SCORE IN SURGICALLY NAIVE PATIENTS WITH CROHN'S DISEASE

RISANKIZUMAB INDUCTION THERAPY PROVIDES EARLY SYMPTOM IMPROVEMENTS IN ABDOMINAL PAIN AND STOOL FREQUENCY IN PATIENTS WITH MODERATE TO SEVERE CROHN'S DISEASE: RESULTS FROM TWO PHASE 3 INDUCTION STUDIES
RISANKIZUMAB INDUCTION THERAPY PROVIDES EARLY SYMPTOM IMPROVEMENTS IN ABDOMINAL PAIN AND STOOL FREQUENCY IN PATIENTS WITH MODERATE TO SEVERE CROHN'S DISEASE: RESULTS FROM TWO PHASE 3 INDUCTION STUDIES

SUCCINATE RECEPTOR (SUCNR1) MEDIATES LEUKOCYTE-ENDOTHELIAL CELL INTERACTIONS INDUCED BY TNF?
SUCCINATE RECEPTOR (SUCNR1) MEDIATES LEUKOCYTE-ENDOTHELIAL CELL INTERACTIONS INDUCED BY TNF?

CLINICAL AND ULTRASONOGRAPHIC ENTHESITIS IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH AND WITHOUT PSORIASIS
CLINICAL AND ULTRASONOGRAPHIC ENTHESITIS IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH AND WITHOUT PSORIASIS

CLINICAL CHARACTERISTICS ASSOCIATED WITH BIOCHEMICAL REMISSION THREE MONTHS AFTER DIAGNOSIS OF CROHN'S DISEASE
CLINICAL CHARACTERISTICS ASSOCIATED WITH BIOCHEMICAL REMISSION THREE MONTHS AFTER DIAGNOSIS OF CROHN'S DISEASE

CROHN'S DISEASE ASSOCIATED FIBROSIS MODULATES THE EXPRESSION OF COLLAGEN RECEPTORS
CROHN'S DISEASE ASSOCIATED FIBROSIS MODULATES THE EXPRESSION OF COLLAGEN RECEPTORS

IS LONGER TIME BETWEEN IBD DIAGNOSIS AND FIRST BIOLOGIC INITIATION LEADING TO HIGHER DISEASE SEVERITY AND MORE HOSPITALIZATIONS IN ITALY AND THE UNITED KINGDOM? A COMPARISON TO SIMILAR METRICS IN THE UNITED STATES
IS LONGER TIME BETWEEN IBD DIAGNOSIS AND FIRST BIOLOGIC INITIATION LEADING TO HIGHER DISEASE SEVERITY AND MORE HOSPITALIZATIONS IN ITALY AND THE UNITED KINGDOM? A COMPARISON TO SIMILAR METRICS IN THE UNITED STATES

MRI FOLLOW UP IN ACTIVE PERIANAL FISTULIZING CROHN'S DISEASE REFRACTORY TO ANTI-TUMOR NECROSIS FACTOR THERAPY RECEIVING USTEKINUMAB
MRI FOLLOW UP IN ACTIVE PERIANAL FISTULIZING CROHN'S DISEASE REFRACTORY TO ANTI-TUMOR NECROSIS FACTOR THERAPY RECEIVING USTEKINUMAB

SAFETY OF VEDOLIZUMAB AND USTEKINUMAB IN ELDERLY IBD PATIENTS: A REAL-LIFE MULTICENTRIC COHORT STUDY
SAFETY OF VEDOLIZUMAB AND USTEKINUMAB IN ELDERLY IBD PATIENTS: A REAL-LIFE MULTICENTRIC COHORT STUDY

Item 81 - 100 / 568
1 2 3 4
5
6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29